Dynavax Technologies Corporation (LON:0IDA)
London flag London · Delayed Price · Currency is GBP · Price in USD
15.39
+4.28 (38.56%)
At close: Dec 24, 2025

Dynavax Technologies Revenue

Dynavax Technologies had revenue of $94.88M USD in the quarter ending September 30, 2025, with 17.67% growth. This brings the company's revenue in the last twelve months to $330.51M, up 26.73% year-over-year. In the year 2024, Dynavax Technologies had annual revenue of $277.25M with 19.36% growth.

Revenue (ttm)
$330.51M
Revenue Growth
+26.73%
P/S Ratio
5.45
Revenue / Employee
$816.08K
Employees
405
Market Cap
1.34B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024277.25M44.96M19.36%
Dec 31, 2023232.28M-490.40M-67.86%
Dec 31, 2022722.68M283.24M64.45%
Dec 31, 2021439.44M392.89M844.00%
Dec 31, 202046.55M11.33M32.18%
Dec 31, 201935.22M27.02M329.60%
Dec 31, 20188.20M7.87M2,407.03%
Dec 31, 2017327.00K-10.72M-97.04%
Dec 31, 201611.04M6.99M172.67%
Dec 31, 20154.05M-6.98M-63.29%
Dec 31, 201411.03M-219.00K-1.95%
Dec 31, 201311.25M1.54M15.82%
Dec 31, 20129.71M-11.90M-55.06%
Dec 31, 201121.61M-2.34M-9.75%
Dec 31, 201023.95M-16.37M-40.60%
Dec 31, 200940.32M3.22M8.69%
Dec 31, 200837.09M23.00M163.21%
Dec 31, 200714.09M9.25M190.76%
Dec 31, 20064.85M-9.81M-66.93%
Dec 31, 200514.66M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.17B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
Genus672.80M
HUTCHMED (China)439.54M
Revenue Rankings